 |
Undergraduate
What
is Physiology?
Careers
Brochure
Questions
Physiologists Ask
Meet
a Physiologist
Explore
Physiology
Career
Decisions
Awards
Available
Minority
Resources
Educators
& Outreach
Related
Links
 |
 |
Who is Magdalena Alonso-Galicia?
Helping People Through Drug Discovery Research
Magdalena Alonso-Galicia was born in Leon, Guanajuato,
Mexico. Her health was very frail for the first 6 years of her life. She
remembers visiting doctors and hospitals/clinics very frequently. After
having a tonsillectomy and other surgeries, her health problems went away.
This made her realize that she wanted to help cure people’s diseases. She
regarded nurses and clinical lab personnel very highly (they were all so
very nice), but she did not like physicians much. Because she loved
biology and chemistry classes when she was in high school, she decided
that she wanted to help sick people by working in a clinical lab running
the assays that help doctors diagnose patients’ illnesses.
Discovering Research
For college, Maggie decided to attend her home town
university, the University of San Luis Potosi, Mexico, to pursue a
combined degree in chemistry, biology and pharmacy. She enrolled in the
program to become an occupational health specialist. As she was working on
her degree, she got an internship at a hospital running assays.
That was when she discovered that this type of work was not for her. The
routine of running the same assays every day was not exciting for her.
After graduation, she decided to try a job as a
technician in the Department of Physiology in the local School of Medicine
in her home town, doing basic research in the area of renal physiology.
That was when she discovered she loved doing basic research.
Wanting to Learn More
After working for 3 years as a technician, she
realized that she needed to learn more in order to understand the
experiments she was assigned to do. She was considering entering a
graduate program in pharmacology in Mexico. However, her boss recommended
that she move to the US to get access to the best education in integrative
physiology (that is, research that integrates cardiovascular and renal
physiology, also organ or systems physiology; the aim of the program was
to study organ physiology from molecules to how whole organ systems work
in the human body to understand normal body functions with emphasis in
pathophysiological mechanisms that lead to cardiovascular diseases). This
was a research area that he thought would have with a bright future and he
was right. He suggested that Maggie aim very high and apply to the best
graduate schools in the US that offered cardiovascular and/or renal
physiology programs, since she had technical experience in renal
physiology.
So she took his advice and was very excited when she
got accepted to the graduate program in the Department of Physiology &
Biophysics at the University of Mississippi, Medical Center in Jackson,
MS. It was especially exciting as this was the department of Dr. Arthur
Guyton, one of the most extraordinary and respected physiologists and
scientists of all times. Dr. Guyton was an inspiration for her, but it was
her mentor, Dr. John Hall, and the other faculty in the department who
introduced her to the exciting world of integrative cardio-renal
physiology. Her research was on mechanisms of obesity-induced
hypertension. She received her doctoral degree in 1995.
Taking Advantage of Opportunities
Dr. Alonso-Galicia then accepted a postdoctoral
fellowship at the Medical College of Wisconsin in Milwaukee, WI, where she
continued doing research on genetic mechanisms of salt-sensitive
hypertension and the role of arachidonic acid metabolites in hypertension.
While in the last year of her postdoctoral training, a professor at the
Medical College of Wisconsin recommended her for a basic research position
at Merck Research Laboratories. She applied and, after two rounds of
interviews and a seminar presentation, she got a job offer. Even though
she’d always planned to pursue a career in academia and never thought that
she would work in a pharmaceutical company, it was an offer she could not
turn down because of Merck’s reputation and strong support for basic
research in drug discovery. It was a way she could fulfill her earlier
desire to help people who had diseases.
Working for a Drug Company
Currently, Dr. Alonso-Galicia is a Senior Research
Pharmacologist working in the Department of Cardiovascular Diseases. She
does research to support early drug discovery efforts. Her job requires
that she stay current in and understand a range of pathophysiological
mechanisms that lead to cardiovascular diseases in order to identify novel
signaling pathways that are amenable for drug targeting.
Away From Work
Dr. Alonso-Galicia loves traveling and meeting people
from all over the world. She also likes interior design and decoration,
going to the movies, reading, listening to music, aerobics classes, and
spending time with her husband and two kittens. She’s considering
volunteering at the local animal shelter to help take care of rescued
animals.
Advice for Undergraduate Students
Visit and if possible do an internship in a
Department of Physiology to find out what area of physiology you would
like to get involved in.
Recent Publications
|
1. |
Alonso-Galicia, M., K.G. Maier, A.S. Greene, A.W.
Cowley, Jr., and R.J. Roman. Role of 20-hydroxyeicosatetraenoic acid in
the renal and vasoconstrictor actions of angiotensin II.
Am.
J. Physiol. Regul. Integr. Comp. Physiol. 283: R60-R68, 2002.
|
|
2. |
Kunet, M.P., R.J. Roman, M. Alonso-Galicia, J.R.
Falck, and J.H. Lombard. Cytochrome P-450 omega-hydroxylase: a potential
oxygen sensor in rat arterioles and skeletal muscle.
Am. J. Physiol. Heart Circ. Physiol. 280: H1840-H1845, 2001.
|
|
3. |
Maier, K.G., L. Henderson, J. Narayanan, M.
Alonso-Galicia, J.R. Falck, and R.J. Roman. Fluorescent HPLC assay for
20-HETE and other P-450 metabolites of arachidonic acid.
Am. J. Physiol. Heart Circ. Physiol. 279: H863-H871, 2000.
|
|
4. |
Alonso-Galicia, M., J.R. Falck, K.M. Reddy, and R.J. Roman. 20-HETE agonists and antagonists in the
renal circulation.
Am. J. Physiol. Renal Fluid Electrolyte Physiol. 277: F790-F796, 1999.
|
|
5. |
Roman, R.J., and M. Alonso-Galicia. P450 eicosanoids: a novel signal pathway regulating renal function.
News Physiol. Sci. 14:238-242, 1999.
|
|
6. |
van Dokkum, R.P.E., M. Alonso-Galicia, A.P.
Provoost, H.J. Jacob, and R.J. Roman. Impaired autoregulation of renal
blood flow in the fawn-hooded rat.
Am.
J. Physiol. Regul. Integr. Comp. Physiol. 276: R189-R196, 1999.
|
|
7. |
Alonso-Galicia, M., C. Sun, J.R. Falck, D.R.
Harder, and R.J. Roman. Contribution of 20-HETE to the vasodilator actions
of nitric oxide on renal arteries.
Am. J. Physiol. Renal Fluid Electrolyte Physiol. 275: F370-F378, 1998.
|
|
8. |
Ito, O., M. Alonso-Galicia, K.A. Hopp, and R.J. Roman. Localization of cytochrome P450 4A isoforms
along the rat nephron.
Am. J. Physiol. Renal Fluid Electrolyte Physiol. 274: F395-F404, 1998. |
|
 |